157 related articles for article (PubMed ID: 16443242)
1. Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence.
Célérier E; Ahdepil T; Wikander H; Berrendero F; Nyberg F; Maldonado R
Neuropharmacology; 2006 Jun; 50(7):788-806. PubMed ID: 16443242
[TBL] [Abstract][Full Text] [Related]
2. Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC.
Soria G; Castañé A; Berrendero F; Ledent C; Parmentier M; Maldonado R; Valverde O
Eur J Neurosci; 2004 Oct; 20(8):2203-13. PubMed ID: 15450100
[TBL] [Abstract][Full Text] [Related]
3. Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects.
Rubino T; Forlani G; Viganò D; Zippel R; Parolaro D
J Neurochem; 2005 May; 93(4):984-91. PubMed ID: 15857401
[TBL] [Abstract][Full Text] [Related]
4. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
[TBL] [Abstract][Full Text] [Related]
5. Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice.
Jardinaud F; Roques BP; Noble F
Behav Brain Res; 2006 Oct; 173(2):255-61. PubMed ID: 16884789
[TBL] [Abstract][Full Text] [Related]
6. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
Cichewicz DL; Welch SP
J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
[TBL] [Abstract][Full Text] [Related]
7. The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB
Struik D; Fadda P; Zara T; Zamberletti E; Rubino T; Parolaro D; Fratta W; Fattore L
Pharmacol Res; 2017 Jan; 115():209-217. PubMed ID: 27890818
[TBL] [Abstract][Full Text] [Related]
8. Behavioral effects of the novel cannabinoid full agonist AM 411.
McLaughlin PJ; Lu D; Winston KM; Thakur G; Swezey LA; Makriyannis A; Salamone JD
Pharmacol Biochem Behav; 2005 May; 81(1):78-88. PubMed ID: 15894067
[TBL] [Abstract][Full Text] [Related]
9. Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated by CB1 and CB2 receptor coupled pathways.
Verhoeckx KC; Korthout HA; van Meeteren-Kreikamp AP; Ehlert KA; Wang M; van der Greef J; Rodenburg RJ; Witkamp RF
Int Immunopharmacol; 2006 Apr; 6(4):656-65. PubMed ID: 16504929
[TBL] [Abstract][Full Text] [Related]
10. Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain.
Ozaita A; Puighermanal E; Maldonado R
J Neurochem; 2007 Aug; 102(4):1105-14. PubMed ID: 17484726
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous cannabinoid withdrawal produces a differential time-related responsiveness in cannabinoid CB1 receptor gene expression in the mouse brain.
Oliva JM; Ortiz S; Palomo T; Manzanares J
J Psychopharmacol; 2004 Mar; 18(1):59-65. PubMed ID: 15107186
[TBL] [Abstract][Full Text] [Related]
12. Effects of nandrolone on acute morphine responses, tolerance and dependence in mice.
Célérier E; Yazdi MT; Castañé A; Ghozland S; Nyberg F; Maldonado R
Eur J Pharmacol; 2003 Mar; 465(1-2):69-81. PubMed ID: 12650835
[TBL] [Abstract][Full Text] [Related]
13. Acute delta9-tetrahydrocannabinol exposure facilitates quinpirole-induced hyperlocomotion.
Gorriti MA; Ferrer B; del Arco I; Bermúdez-Silva FJ; de Diego Y; Fernandez-Espejo E; Navarro M; Rodríguez de Fonseca F
Pharmacol Biochem Behav; 2005 May; 81(1):71-7. PubMed ID: 15894066
[TBL] [Abstract][Full Text] [Related]
14. Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine.
Valjent E; Mitchell JM; Besson MJ; Caboche J; Maldonado R
Br J Pharmacol; 2002 Jan; 135(2):564-78. PubMed ID: 11815392
[TBL] [Abstract][Full Text] [Related]
15. Chronic treatment with Delta(9)-tetrahydrocannabinol impairs spatial memory and reduces zif268 expression in the mouse forebrain.
Boucher AA; Vivier L; Metna-Laurent M; Brayda-Bruno L; Mons N; Arnold JC; Micheau J
Behav Pharmacol; 2009 Feb; 20(1):45-55. PubMed ID: 19179850
[TBL] [Abstract][Full Text] [Related]
16. Exposure to marijuana smoke impairs memory retrieval in mice.
Niyuhire F; Varvel SA; Martin BR; Lichtman AH
J Pharmacol Exp Ther; 2007 Sep; 322(3):1067-75. PubMed ID: 17586723
[TBL] [Abstract][Full Text] [Related]
17. Modulation of extracellular signal-regulated kinases cascade by chronic delta 9-tetrahydrocannabinol treatment.
Rubino T; Forlani G; Viganò D; Zippel R; Parolaro D
Mol Cell Neurosci; 2004 Mar; 25(3):355-62. PubMed ID: 15033164
[TBL] [Abstract][Full Text] [Related]
18. Repeated exposure to Delta(9)-tetrahydrocannabinol alters heroin-induced locomotor sensitisation and Fos-immunoreactivity.
Singh ME; McGregor IS; Mallet PE
Neuropharmacology; 2005 Dec; 49(8):1189-200. PubMed ID: 16137723
[TBL] [Abstract][Full Text] [Related]
19. The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Delta9-tetrahydrocannabinol.
Verty AN; McGregor IS; Mallet PE
Brain Res; 2004 Sep; 1020(1-2):188-95. PubMed ID: 15312802
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of cannabinoids in the elevated plus maze.
Onaivi ES; Green MR; Martin BR
J Pharmacol Exp Ther; 1990 Jun; 253(3):1002-9. PubMed ID: 2162942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
